Apple Inc. (NASDAQ:AAPL) ResearchKit is leading to medical research getting more participation from volunteers which could mean breakthroughs in the fight to find cures to different diseases.
Ron Winslow also adds in an interview on The Wall Street Journal’s Lunch Break with Tanya Rivero that it is not only researchers who are finding great benefits from the new research platform Apple Inc. (NASDAQ:AAPL), patients are also liking the capabilities of the new platform.
“For all five [of these early apps powered by ResearchKit], the total is about 60,000 as of now which is a remarkable amount. One researcher I talked to in a breast cancer trial just spent with her colleagues three years sending out 60,000 notices to enroll 350 patients in a similar kind of trial. This kind of access that is geographically-agnostic – you can be anywhere [and] you don’t have to live next to an academic center to do this – really opens up the field for more participation,” Winslow tells Rivero.
Furthermore, the new apps for medical research have become more transparent with people about their results because of ResearchKit, Winslow, The Wall Street Journal’s deputy bureau chief for health and science, explains to Rivero.
“One of the things that they do – researchers said and a few of the patients that I talked to – they seem to hold the promise of actually giving the patients feedback on their own data. If you’re in a conventional trial, […] the data is compiled, and conclusions are reached at the end of the trial. In these trials [with ResearchKit], you’ll get the data back right away and you can actually see what your own improvement or decline might be and see if there is something that you might be able to do to make things better,” Winslow explains.
Apple Inc. (NASDAQ:AAPL) announced yesterday that ResearchKit is now available to all medical researchers. The platform launched with just a limited number of partners.
Winslow points out, however, that as with anything uploaded to the Internet, there is always the risk of the data being compromised. Nonetheless, he points out that Apple Inc. (NASDAQ:AAPL) itself does not see the data which is only shared between the patient and the researchers. Furthermore, the patients control when they want to share their data, he adds.
Ken Fisher’s Fisher Asset Management owned about 10.76 million Apple Inc. (NASDAQ:AAPL) shares by the end of the last quarter of 2014.
I just made 84% in 4 days by blindly imitating a hedge fund’s stock pick. I will tell you how I pulled such a huge return in such a short time but let me first explain in this FREE REPORT why following hedge funds’ stock picks is one of the smartest things you can do as an investor. We launched our quarterly newsletter 2.5 years ago and not one subscriber has, since, said ‘I lost money by EXACTLY following your stock picks’. The reason is simple. You can beat index funds by creating a DREAM TEAM of hedge fund managers and investing in only their best ideas. I just made 84% in 4 days by blindly imitating one of these best ideas. CLICK HERE NOW for all the details.
